Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{168154,
        author = {Mashiullah Khan and Neeku Singh and Akshay Sharma and Ashok Kumar},
        title = {Management of Thrombosis Associated with Covishield},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {5},
        pages = {2525-2526},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=168154},
        abstract = {Covishield, the Indian variant of the Oxford-AstraZeneca COVID-19 vaccine, has been pivotal in the global vaccination campaign. However, concerns regarding thrombotic events, particularly Thrombosis with Thrombocytopenia Syndrome (TTS), have emerged. This review discusses the incidence, clinical management, and recommendations for thrombosis associated with Covishield.},
        keywords = {Covishield, thrombosis, Thrombosis with Thrombocytopenia Syndrome, vaccine safety, anticoagulation management.},
        month = {November},
        }